Diabetes-coaching startup Livongo files to go public in a test for health tech
Livongo, a startup that monitors and coaches patients with chronic diseases, on Friday filed papers to launch its initial public offering, in what is seen as a litmus test for health-tech companies seeking to translate early growth into value in the public markets.
The offering is expected to be among the first for a new generation of slick and savvy venture-backed companies in the U.S. digital health sector, which hasn’t produced an IPO since 2016. (Another such company, medical records data startup Health Catalyst, filed to go public on Thursday.) Livongo’s offering had been anticipated for several months, as the company has been expanding rapidly and running studies to try to show that its services can improve patients’ outcomes and save their employers money.
